BIOPORBioPorto A/S
1.080DKK-2.26%Mkt Cap: 77.88M $P/E:

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Pricier
1M Perf
Higher
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
RVTY
Revvity, Inc.
$12.41BUSDP/E 53.5
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap77.88M $
Enterprise Value70.98M $
Revenue (TTM)5.87M $
Gross Profit4.43M $
Net Income (TTM)-11.96M $
Revenue/Share0.0109 USD
Last Price1.080 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
CountryDK
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-15.43
PEG
EV/EBITDA-6.28
EV/Revenue12.10
P/S13.27
P/B8.50
EPS (TTM)-0.15
EPS (Forward)-0.07
52W Range
0.839035% of range1.526
52W High1.526 DKK
52W Low0.8390 DKK
Profitability
Gross Margin75.44%
Oper. Margin-107.49%
EBITDA Margin-192.72%
Profit Margin-203.83%
ROE-130.33%
ROA-88.13%
Growth
Revenue Growth47.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-11.22M $
CapEx (TTM)
FCF Margin-114.23%
FCF Yield-8.61%
Net Debt-6.90M $
Net Debt/EBITDA0.61
Balance Sheet
Debt/Equity0.12
Current Ratio3.25
Quick Ratio2.81
Book Value/Sh0.1270 DKK
Cash/Share0.1110 DKK
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 DKK
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)1.750 DKK
Upside (mean)+62.0%
Target Range1.750 DKK1.750 DKK
# Analysts1
Ownership
Shares Out.495.10M
Float458.86M
Insiders29.80%
Institutions6.22%
Technical
SMA 501.163 (-7.1%)
SMA 2001.091 (-1.0%)
Beta1.38
S&P 52W Chg20.05%
Avg Vol (30d)393.28K
Avg Vol (10d)168.38K
Technical Indicators
RSI (14)37.6
MACD-0.0223
MACD Signal-0.0068
MACD Hist.-0.0155
BB Upper1.339 DKK
BB Middle1.183 DKK
BB Lower1.028 DKK
BB Width26.20%
ATR (14)0.0521 DKK
Vol Ratio (20d)0.49x